Women's experience of maternal serum screening

Canadian Family Physician

Volumn 46, Issue MAR., 2000, Pages 614-620

  Carroll, J C ^a   Brown, J B ^a   Reid, A J ^a   Pugh, P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO HEALTH; DECISION MAKING; DOCTOR PATIENT RELATION; EMPIRICAL APPROACH; FEMALE; GENERAL PRACTICE; GENETIC SCREENING; GENETICS AND REPRODUCTION; HEALTH SERVICE; HUMAN; PATIENT SATISFACTION; PREGNANCY; PRENATAL CARE;

EMPIRICAL APPROACH; GENETICS AND REPRODUCTION;

ADOLESCENT; ADULT; DECISION MAKING; FAMILY PRACTICE; FEMALE; GENETIC SCREENING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MATERNAL HEALTH SERVICES; PATIENT SATISFACTION; PHYSICIAN-PATIENT RELATIONS; PREGNANCY; PRENATAL CARE;

EID: 0034154768     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 1988;297:883-7.
2. Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Canick JA, et al. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 1992;327:588-93.
3. Cheng EY, Luthy DA, Zebelman AM, Williams MA, Lieppman RE, Hickoc DE. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. Obstet Gynecol 1993;81:72-7.
4. Wald NJ, Kennard A, Densem JW, Cuckle HS, Chard T, Butler L, Antenatal maternal serum screening for Down's syndrome: results of a demonstration project. BMJ 1992;305:3914.
5. Chodirker BN, Evans JA. Maternal serum AFP screening programs: the Manitoba experience. In: Current practice of prenatal diagnosis in Canada. Research Studies. Volume 13. Ottawa, Ont: Royal Commission on New Reproductive Technologies 1993. p. 535-610.
6. Carroll JC, Reid AJ, Woodward CA, Permaul-Woods JA, Domb S, Ryan G, et al. Ontario Maternal Serum Screening Program: practices, knowledge and opinions of health care providers. Can Med Assoc J 1997;156:775-84.
7. Green JM. Serum screening for Down's syndrome: experiences of obstetricians in England and Wales. BMJ 1994;309:769-72.
8. Yankowitz J, Howser DM, Ely JW. Differences in practice patterns between obstetricians and family physicians: use of serum screening. Am J Obstet Gynecol 1996;174:1361-5.
9. Faden RR, Chwalow AJ, Orel-Crosby E, Holtzman NA, Chase GA, Leonard CO. What participants understand about a maternal serum alpha-fetoprotein screening program. Am J Public Health 1985;75:1381-4.
10. Goel V, Glazier R, Holzapfel S, Pugh P, Summers A. Evaluating patient's knowledge of maternal serum screening. Prenat Diagn 1996;16:425-30.
11. Marteau TM, Cook R, Kidd J, Michie S, Johnston M, Slack J, et al. The psychological effects of false-positive results in prenatal screening for fetal abnormality: a prospective study. Prenat Diagn 1992;12:205-14.
12. Marteau TM. Towards informed decisions about prenatal testing: a review. Prenat Diagn 1995;15:1215-26.
13. Mays N, Pope C. Rigour and qualitative research. BMJ 1995;311:109-12.
14. Mays N, Pope C. Observational methods in health care settings. BMJ 1995;311:182-4.
15. Morgan DL. Focus groups as qualitative research. Newbury Park, Calif: Sage Publications; 1988.
16. Morgan DL. Successful focus groups: advancing the state of the art. Newbury Park, Calif: Sage Publications; 1993.
17. Patton M. Qualitative evaluation and research methods. 2nd ed. Newbury Park, Calif: Sage Publications; 1990.
18. Krueger RA. Focus groups: a practical guide for applied research. 2nd ed. Thousand Oaks, Calif: Sage Publications; 1994.
19. Brown JB, McWilliam CL, Mai V. Barriers and facilitators to seniors' independence. Perceptions of seniors, caregivers, and health care providers. Can Fam Physician 1997;43:469-75.
20. Brown JB, Dickie I, Brown L, Biehn J. Long-term attendance at a family practice teaching unit. Qualitative study of patients' views. Can Fam Physician 1997;43:901-6.
21. Pope C, Mays N. Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. BMJ 1995;311:42-5.
22. Glazier RH, Goel V, Holzapfel S, Summers A, Pugh P, Yeung M. Written patient information about triple-marker screening: a randomized controlled trial. Obstet Gynecol 1997;90(5)769-74.
23. Roelofsen EEC, Kamerbeek LI, Tymstra TJ, Beekhuis JR, Mantingh A. Women's opinions on the offer and use of maternal serum screening. Prenat Diagn 1993;13:741-7.
24. Marteau TM, Slack J, Kidd J, Shaw RW. Presenting a routine screening test in antenatal care: practice observed. Public Health 1992;106:13141.
25. Smith DK, Shaw RW, Marteau TM. Informed consent to undergo serum screening for Down's syndrome: the gap between policy and practice. BMJ 1994;309:776.
26. Statham H, Green J. Serum screening for Down's syndrome: some women's experiences. BMJ 1993;307:174-6.
27. Gekas J, Gondry J, Mazur S, Cesbron P, Thepot F. Informed consent to serum screening for Down syndrome: are women given adequate information? Prenat Diag 1999;19:1-7.
28. Jorgensen FS. User acceptability of an alpha-fetoprotein screening programme. Dan Med Bull 1995;42:100-5.
29. Farber NB. The process of pregnancy resolution among adolescent mothers. Adolescence 1991;26(103):697-716.
30. Resnick MD, Bearinger LH, Stark P, Blum RW. Patterns of consultation among adolescent minors obtaining an abortion. Am J Orthopsychiatry 1994;64(2):310-6.
31. Brown JB, Weston WW, Stewart M. The third component: finding common ground. In: Stewart M, Brown JB, Weston WW, McWhinney IR, McWilliam CL, Freeman TR, editors. Patient-centred medicine: transforming the clinical method. Thousand Oaks, Calif: Sage Publications; 1995. p. 59-72.